§ 13F · FUND PROFILE
B Group, Inc..
AUM · $213M (13F)Positions · 19Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
No new positions
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | QQQ | INVESCO QQQ TR | 50K | $37M | — | — |
| 2 | ADMA | ADMA BIOLOGICS INC | 3.26M | $27M | — | — |
| 3 | PALI | PALISADE BIO INC | 11.41M | $24M | — | — |
| 4 | NRXP | NRX PHARMACEUTICALS INC | 4.09M | $17M | — | — |
| 5 | SNSE | FAETH THERAPEUTICS INC | 610K | $15M | — | — |
| 6 | TSHA | TAYSHA GENE THERAPIES INC | 1.80M | $12M | — | — |
| 7 | PRAX | PRAXIS PRECISION MEDICINES I | 33K | $11M | — | — |
| 8 | CLLS | CELLECTIS S A | 3.28M | $10M | — | — |
| 9 | ZLAB | ZAI LAB LTD | 451K | $9M | — | — |
| 10 | GPCR | STRUCTURE THERAPEUTICS INC | 140K | $8M | — | — |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE B SIGNAL
AC read
B Group, Inc. is a Other fund managing $213 million in assets. The fund runs a focused portfolio of just 19 positions.
Read the full dossier →